115 related articles for article (PubMed ID: 3819448)
1. Structural variations in the H-2 genes of AKR lymphomas.
Hui K; Minamide L; Prandoni N; Festenstein H; Grosveld FG
J Immunogenet; 1986; 13(2-3):117-21. PubMed ID: 3819448
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a polymorphic class I MHC gene in the AKR lymphoma K36.16.
Sim BC; Hui KM
J Immunogenet; 1989; 16(4-5):335-41. PubMed ID: 2639906
[TBL] [Abstract][Full Text] [Related]
3. Promotion of tumor growth by transfecting antisense DNA to suppress endogenous H-2Kk MHC gene expression in AKR mouse thymoma.
Hui KM; Sim BC; Foo TT; Oei AA
Cell Immunol; 1991 Aug; 136(1):80-94. PubMed ID: 2060026
[TBL] [Abstract][Full Text] [Related]
4. Aberrant H-2-like allospecificities on K36.16 thymoma. Studies by radiobinding and immunoprecipitation with anti-H-2 monoclonal antibodies.
Festenstein H; Hui KM
J Immunogenet; 1986; 13(2-3):113-6. PubMed ID: 3819447
[TBL] [Abstract][Full Text] [Related]
5. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
6. Dominant allele-specific regulation of expression of H-2Kk gene products revealed by somatic cell hybridization.
Bishop CE; Lewis CM; Festenstein H
Somatic Cell Genet; 1982 Sep; 8(5):623-34. PubMed ID: 7135165
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
[TBL] [Abstract][Full Text] [Related]
8. Apparent alteration in MHC antigens in K36.16, an AKR thymoma, does not result in genetic rearrangement.
Lewis CM; Bishop CE
Immunology; 1983 Nov; 50(3):433-40. PubMed ID: 6629416
[TBL] [Abstract][Full Text] [Related]
9. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
Schmidt W; Festenstein H
J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
[TBL] [Abstract][Full Text] [Related]
10. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
Hui K; Grosveld F; Festenstein H
Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639
[TBL] [Abstract][Full Text] [Related]
11. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
Schmidt W; Festenstein H
Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
[TBL] [Abstract][Full Text] [Related]
12. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice.
Yetter RA; Morse HC
J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb.
Chinsky J; Lilly F; Childs G
Proc Natl Acad Sci U S A; 1985 Jan; 82(2):565-9. PubMed ID: 3855567
[TBL] [Abstract][Full Text] [Related]
14. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
15. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
Schmidt W
Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
[TBL] [Abstract][Full Text] [Related]
16. [Detection of DNA sequences sensitive to glucocorticoids in the thymus of AKR mice and their inactivation in thymoma].
Novikova VM; Dashkevich VS; Vishnivetskiĭ SN; Kaledin VI; Mertvetsov NP
Biull Eksp Biol Med; 1986 Nov; 102(11):563-6. PubMed ID: 3779082
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of immunogenicity by AKR leukemic cells following DNA-mediated gene transfer is associated with the reduction of constitutive reactive superoxide radicals.
Chia KY; Lim SP; Oei AA; Sabapathy TK; Hui KM
Int J Cancer; 1994 Apr; 57(2):216-23. PubMed ID: 8157360
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor beta-chain genes in BW5147 and other AKR tumors. Deletion order of murine V beta gene segments and possible 5' regulatory regions.
Lee NE; Davis MM
J Immunol; 1988 Mar; 140(5):1665-75. PubMed ID: 3346546
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of MHC products on AKR lymphoma cells.
Oudshoorn-Snoek M; Demant P
Transplant Proc; 1983 Dec; 15(4):2104-6. PubMed ID: 6424291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
